Advancing IDMP Implementation: Highlights from the Global Pharmaceutical Regulatory Affairs Summit in Brussels

Our CEO Heiner Oberkampf, alongside Dr. Joerg Stueben from Boehringer Ingelheim, recently presented at the Global Pharmaceutical Regulatory Affairs Summit in Brussels on IDMP Ontology (IDMP-O) – Collaborative Implementation of IDMP in Pharma. The session highlighted the growing importance of semantic standards and structured data in regulatory affairs.

‍

The presentation focused on three key areas:

‍

1. Pharma use cases for IDMP-O — demonstrating how the ontology supports diverse regulatory and operational scenarios.
2. Results from the EMA PMS Data Alignment Proof of Concept (PoC) — showcasing the practical benefits of applying IDMP-O to enhance data alignment across regulatory workflows.

‍

Key insights from the IDMP-O Maturity Benchmark Survey — providing a snapshot of industry readiness and adoption trends.

‍

Heiner and Joerg received positive feedback from Veronica Lipucci Di Paola and Isabel Chícharo at the European Medicines Agency, as well as from their partner MAIN5, for the collaborative efforts in these initiatives.

‍

The summit also featured insights from industry leaders such as Quentin Darrasse, on knowledge graph-based master data management enabling end-to-end regulatory information management, and Kepa Amutxastegi, on achieving regulatory operational excellence through data governance.

‍

Heiner emphasized the ongoing mission: to unlock the full potential of semantic data standards with IDMP Ontology, fostering more efficient, interoperable, and connected regulatory processes.

‍

The event concluded on a high note, with a special thanks to Franziska Dukatz from Deloitte for organizing a memorable dinner that facilitated deeper industry discussions.